A five-year analysis of disease spectrum and clinical features of rheumatic inpatients in a new general hospital

LIANG Dong-bin; TAO Li-hua; XU Jing; GUO Qian; LI Ji; SHI Lian-jie

doi:10.16766/j.cnki.issn.1674-4152.001988

Volume 19 Issue 7

Jul. 2021

Turn off MathJax

Article Contents

Article Navigation > Chinese Journal of General Practice > 2021 > 19(7): 1075-1078

LIANG Dong-bin, TAO Li-hua, XU Jing, GUO Qian, LI Ji, SHI Lian-jie. A five-year analysis of disease spectrum and clinical features of rheumatic inpatients in a new general hospital[J]. Chinese Journal of General Practice, 2021, 19(7): 1075-1078. doi: 10.16766/j.cnki.issn.1674-4152.001988

Citation:

LIANG Dong-bin, TAO Li-hua, XU Jing, GUO Qian, LI Ji, SHI Lian-jie. A five-year analysis of disease spectrum and clinical features of rheumatic inpatients in a new general hospital[J]. Chinese Journal of General Practice, 2021, 19(7): 1075-1078. doi: 10.16766/j.cnki.issn.1674-4152.001988

Citation:

LIANG Dong-bin, TAO Li-hua, XU Jing, GUO Qian, LI Ji, SHI Lian-jie. A five-year analysis of disease spectrum and clinical features of rheumatic inpatients in a new general hospital[J]. Chinese Journal of General Practice, 2021, 19(7): 1075-1078. doi: 10.16766/j.cnki.issn.1674-4152.001988

PDF( 1296 KB)

A five-year analysis of disease spectrum and clinical features of rheumatic inpatients in a new general hospital

doi: 10.16766/j.cnki.issn.1674-4152.001988

Department of Rheumatology and Immunology, Peking University International Hospital, Beijing 102206, China

Funds:

81501396

YN2017QX01

YN2020ZD01

Received Date: 2021-01-12
Available Online: 2022-02-16

Abstract

Abstract

Objective To understand the disease spectrum distribution and general characteristics of inpatients in the Department of Rheumatology and immunology in China. Methods The clinical data of inpatients in the Department of Rheumatology and Immunology of Peking University International Hospital from January 2015 to December 2019, including gender, age, diagnosis and length of stay, were collected for statistical description and analysis. Results There were 22 beds, 229 patients discharged in total, and 1 236 non-repeat inpatients. The mean age was (51.14±16.74) years. Of all the patients, 947 patients were no more than 65 years (76.62%). The ratio of female to male was 1.81 ∶ 1. The most frequent rheumatic diseases inpatient was following, RA 25.29%, SS 11.30%, SLE 8.59%, Gout 8.43%, OA 7.65%, SpA 5.70%, and each of the other rheumatic diseases was less than 3%. The number of discharged patients increased year by year, with 56, 282, 542, 595 and 752 cases in each year, respectively. However, the number of repetitive inpatients increased. Different rheumatic diseases showed different hospital days, and patients with IIM need the longest hospital days [(19.79±11.86) d], and the average length of hospital stay of SSc was (16.54±8.48) days. The proportion of RA patients who were admitted to hospital repeatedly was 8.64%, but this proportion of IIM patients and SSc patients was 32.14% and 34.60%, respectively (all P < 0.001). Conclusion Most of the rheumatic inpatients were female and less than 65 years. Arthritis disease was still the main type of hospitalization in rheumatic disease. Patients with IIM or SSc need longer hospital stay and show a higher proportion of repeated hospitalization than patients with other rheumatic diseases.
- Rheumatic disease,
- Inpatients,
- Disease spectrum,
- Proportion

FullText(HTML)

References(16)

References

[1]	张奉春. 第二次全国风湿免疫专科医师调查报告[J]. 中华临床免疫和变态反应杂志, 2014, 8(3): 165-169. https://www.cnki.com.cn/Article/CJFDTOTAL-OZHL201403001.htm
[2]	王涛, 李志军. 类风湿关节炎的诊断与治疗[J]. 中华全科医学, 2020, 18(2): 170-171.
[3]	MATHEW A J, DANDA D, CONAGHAN P G. MRI and ultrasound in rheumatoid arthritis[J]. Curr Opin Rheumatol, 2016, 28(3): 323-329. http://www.onacademic.com/detail/journal_1000039412750810_73ae.html
[4]	YE H, SU Y, LI R, et al. Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort[J]. Clin Rheumatol, 2016, 35(10): 2397-2401. doi: 10.1007/s10067-016-3281-2
[5]	ZHANG S, WANG Y, PENG L, et al. Comparison of clinical features in HLA-b27 positive and negative patients with axial spondyloarthritis: Results from a cohort of 4, 131 patients[J]. Front Med(Lausanne), 2020, 7: 609562. http://www.researchgate.net/publication/347900110_Comparison_of_Clinical_Features_in_HLA-B27_Positive_and_Negative_Patients_With_Axial_Spondyloarthritis_Results_From_a_Cohort_of_4131_Patients
[6]	FANOURIAKIS A, KOSTOPOULOU M, CHEEMA K, et al. 2019 Update of the joint european league against rheumatism and european renal association-european dialysis and transplant association(EULAR/ERA-EDTA) recommendations for the management of lupus nephritis[J]. Ann Rheum Dis, 2020, 79(6): 713-723. doi: 10.1136/annrheumdis-2020-216924
[7]	ARINGER M, COSTENBADER K, DAIKH D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(9): 1151-1159. doi: 10.1136/annrheumdis-2018-214819
[8]	MARIAMPILLAI K, GRANGER B, AMELIN D, et al. Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies[J]. JAMA Neurol, 2018, 75(12): 1528-1537. doi: 10.1001/jamaneurol.2018.2598
[9]	SEROR R, BOWMAN S J, BRITO-ZERON P, et al. EULAR Sjogren's syndrome disease activity index(ESSDAI): A user guide[J]. RMD Open, 2015, 1(1): e000022. doi: 10.1136/rmdopen-2014-000022
[10]	谢长好, 李志军. 系统性红斑狼疮的诊断与治疗[J]. 中华全科医学, 2020, 18(4): 527-528. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202004002.htm
[11]	SHIBOSKI C H, SHIBOSKI S C, SEROR R, et al. 2016 American College of Rheumatology/European league against rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts[J]. Arthritis Rheumatol, 2017, 69(1): 35-45. http://smartsearch.nstl.gov.cn/paper_detail.html?id=a16c81cd33d2923e59416a82d4798256
[12]	LI Y, JIA X, SUN X, et al. Risk factors for cancer-associated myositis: A large-scale multicenter cohort study[J]. Int J Rheum Dis, 2021, 24(2): 268-273.
[13]	VOLKMANN E R, VARGA J. Emerging targets of disease-modifying therapy for systemic sclerosis[J]. Nat Rev Rheumatol, 2019, 15(4): 208-224. http://www.onacademic.com/detail/journal_1000041601885999_c7d9.html
[14]	VACCHI C, SEBASTIANI M, CASSONE G, et al. Therapeutic options for the treatment of interstitial lung disease related to connective tissue diseases. a narrative review[J]. J Clin Med, 2020, 9(2): 407. http://www.researchgate.net/publication/339074498_Therapeutic_Options_for_the_Treatment_of_Interstitial_Lung_Disease_Related_to_Connective_Tissue_Diseases_A_Narrative_Review
[15]	MANFREDI A, SEBASTIANI M, CERRI S, et al. Prevalence and characterization of non-sicca onset primary Sjogren syndrome with interstitial lung involvement[J]. Clin Rheumatol, 2017, 36(6): 1261-1268. http://smartsearch.nstl.gov.cn/paper_detail.html?id=5fb1bcb1076f285369dec2bcb3e994d1
[16]	ROCA F, DOMINIQUE S, SCHMIDT J, et al. Interstitial lung disease in primary Sjogren's syndrome[J]. Autoimmun Rev, 2017, 16(1): 48-54. http://smartsearch.nstl.gov.cn/paper_detail.html?id=8872cf04e04716f62c310183c0689a86